Why Clover Health Stock Fell in February
Shares of Clover Health Investments (NASDAQ: CLOV) fell 32.6% in February, according to data provided by S&P Global Market Intelligence, after the company was targeted by short-seller Hindenburg Research. Hindenburg called Clover Health "a broken company" and provided a good enough argument to cause some investors to walk away from the stock.
Clover became public through one of the special purpose acquisition companies (SPACs) backed by billionaire investor Chamath Palihapitiya. Clover is a medical insurance provider focused on Medicare Advantage plans that uses internally developed tech to try to improve patient outcomes, and their payments.
Image source: Getty Images.
Source Fool.com
